Company family
Septa: medicine shortages
As of 2 Nov 2026, 15 Septa products have a reported shortage across 1 countries, covering 7 medicines.
Where
Which therapeutic classes
Why, compared with all companies
Manufacturing problems point to the company's own supply chain; increased demand often follows a competitor's shortage or a demand shock.
Latest changes
All changesNo changes recorded yet. Changes are tracked from our daily snapshots.
When its current shortages began
Long-run trend in Canada
Canada dashboardCanada publishes every report since 2017, so it shows whether this company is reporting more or fewer shortages over time. The current year is partial.
Against its peers
Breadth vs depth
Further right: more products short. Higher: more different medicines affected.
Medicines short
Download CSV| Medicine | Where this company is short | Products | Earliest start | Main reason | Short anywhere |
|---|---|---|---|---|---|
| Citalopram | 3 | 15 Jun 2017 | Other | 5/16 | |
| Donepezil | 3 | 28 Nov 2018 | Other | 8/16 | |
| Losartan | 3 | 3 Oct 2018 | Other | 6/16 | |
| Amlodipine | 2 | 21 May 2020 | Other | 8/16 | |
| Zopiclone | 2 | 20 Jun 2017 | Other | 3/16 | |
| Metformin | 1 | 24 Nov 2017 | Other | 8/16 | |
| Zolmitriptan | 1 | 27 Jun 2017 | Manufacturing problem | 4/16 |
Shortage data describes supply, not company finances. A shortage can mean lost sales for the supplier or extra demand for its competitors. Nothing here is investment advice; tickers are for identification only and may be out of date.